Stay updated on Dapagliflozin in Acute Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Acute Heart Failure Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check10 days agoChange DetectedNo substantive changes detected; core study details appear unchanged.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedAdded a site revision tag (Revision: v3.4.2) and removed older funding-status notices (Revision: v3.4.1). These changes affect only the site metadata and do not modify the study details or eligibility information.SummaryDifference0.5%

- Check38 days agoChange DetectedA site-wide notice about government funding and NIH operations was added. The site revision number was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check45 days agoChange DetectedAdded a Show glossary option and new metadata labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus a page revision note 'Revision: v3.4.0'. Older labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were removed and the revision updated from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check59 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin in Acute Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.